Co-Target(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T93627 | Target Info | |||
| Target Name | Human immunodeficiency virus GAG protein (HIV gag) | ||||
| Synonyms |
Pr55Gag; Gag polyprotein
Click to Show/Hide
|
||||
| Target Type | Clinical trial Target | ||||
| Gene Name | HIV gag | ||||
| UniProt ID | |||||
| Co-Targets of This Target | Top | |||||
|---|---|---|---|---|---|---|
| Co-Target Name | Human immunodeficiency virus Gag-Pol polyprotein (HIV gag-pol) | Co-Target | ||||
| UniProt ID | POL_HV1H2 | |||||
| Gene Name | HIV gag-pol | |||||
| Synonyms |
Human immunodeficiency virus Pr160Gag-Pol
Click to Show/Hide
|
|||||
| Representative Drug(s) | Bevirimat | Drug Info | EC50 = 10 nM | [1] | ||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation. Bioorg Med Chem Lett. 2018 May 15;28(9):1550-1557. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.